The Food and Drug Administration (FDA) has granted accelerated approval for Lynparza (olaparib; AstraZeneca) for the treatment of advanced ovarian cancer associated with defective BRCA genes.
The Food and Drug Administration (FDA) is warning consumers that fetal ultrasound imaging and Doppler fetal ultrasound heartbeat monitors are prescription devices designed to be used by trained healthcare professionals and are not intended for over-the-counter (OTC) sale or use for creating fetal keepsake images and videos.
The Centers for Disease Control and Prevention (CDC) has released its annual fact sheet of the three reported sexually transmitted diseases (STDs): chlamydia, gonorrhea, and syphilis.
The Food and Drug Administration (FDA) has granted the first-ever waiver under specific laboratory regulation for Syphilis Health Check test to be used in expanded healthcare settings.
The Food and Drug Administration (FDA) has approved Gardasil 9 (9-valent human papillomavirus types, recombinant; Merck) vaccine for the prevention of cervical, vulvar, vaginal, anal cancers, and for the prevention of genital warts caused by nine types of human papillomavirus (HPV).
BioPharmX announced the launch of Violet iodine, a first-of-its-kind pill for relief of premenstrual breast discomfort.
The birth rate declined in the United States for the sixth straight year in 2013, with the general fertility rate at an all-time low.
The Food and Drug Administration (FDA) has issued a final rule to standardize how information is presented in labeling of prescription drugs and biologics regarding the use of medicines during pregnancy and breastfeeding.
The Food and Drug Administration (FDA) is warning against the use of laparoscopic power morcellators in hysterectomy or myomectomy procedures for the majority of women.
According to research presented at the American Heart Association's Scientific Sessions 2014, adults whose mothers were overweight or obese pre-pregnancy may have a significantly increased risk of dying from heart disease or stroke.
Taking a three-drug regimen during pregnancy prevented mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor, and then two more after giving birth, according to results of an ongoing international clinical trial.
Certain chemicals used in sunscreens and other personal care products have been linked to reduced fecundity in men, according to a study appearing in the American Journal of Epidemiology.
Genentech announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with chemotherapy for the treatment of women with platinum-resistant, recurrent ovarian cancer.
Mission Pharmacal announced the launch of CitraNatal basic, an over-the-counter (OTC) prenatal vitamin for pre-pregnancy nutritional support.
A standard prenatal treatment in the United States and other high-income countries for pregnant women at high risk for preterm birth may potentially cause harm if implemented in low-income countries, according to new findings.
The Food and Drug Administration (FDA) has accepted for filing and granted Priority Review to the NDA for palbociclib in combination with letrozole, as a first-line treatment of postmenopausal women with ER+, HER- advanced breast cancer who have not received previous systemic treatment for their advanced disease.
Strong evidence from a new study in human placenta suggests that Endocrine Disrupting Chemicals (EDCs) can interfere with the action of thyroid hormones in pregnant women.
Noven announced that the Food and Drug Administration (FDA) has approved a new indication with a new dose of Minivelle (estradiol transdermal system) for the prevention of postmenopausal osteoporosis.
Rinovum Women's Health announced that the Food and Drug Administration (FDA) has cleared The Stork OTC, the first home-use conception assistance device.
Vasalgel, the first male contraceptive injection, is anticipated to enter its first clinical trial beginning in 2015, according to the Parsemus Foundation.
DiabetOmics announced a new point-of-care test to detect preeclampsia, assess the severity of the disease, and monitor its complications in as early as the 1st trimester.
The Food and Drug Administration (FDA) has granted Fast Track designation to motolimod (VTX-2337; VentiRx) in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.
LabCorp announced the launch of the informaSeq Prenatal Test, a non-invasive prenatal screening assay that can assess for multiple fetal chromosomal aneuploidies, or abnormalities in the number of chromosomes from a single maternal blood draw.
Pfizer announced that it has submitted an NDA to the FDA for palbociclib in combination with letrozole for the treatment of postmenopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer who have not received previous systemic treatment for the advanced disease.
Genentech has announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent, or metastatic cervical cancer.
A new Similac breastfeeding supplement is specially designed to enhance the levels of DHA, lutein, and vitamin E in breastmilk.
Puma Biotechnology announced results from its Phase 3 ExteNET trial of neratinib (PB272) for the extended adjuvant treatment of breast cancer.
The FDA grants Genentech's sBLA for Avastin (bevacizumab) plus chemotherapy Priority Review for the treatment of women with recurrent platinum-resistant ovarian cancer.
The FDA has accepted Genentech's supplemental Biologics License Application (sBLA) and granted Priority Review for Avastin (bevacizumab) plus chemotherapy for the treatment of women with persistent, recurrent or metastatic cervical cancer.
Monistat announced the launch of Monistat Complete Care products, which include a vaginal health test, probiotics, and an odor-neutralizing gel.
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) issued draft updated advice regarding the consumption of fish by pregnant and breastfeeding women and young children.
EffRx announced that the FDA has granted orphan drug designation to EX404 for the treatment of pediatric polycystic ovary syndrome (PCOS).
TherapeuticsMD announced the launch of newly reformulated vitaMedMD RediChew Rx, a branded prescription prenatal vitamin, and Prena1 Chew, a generic prescription prenatal vitamin.
For couples trying to conceive, high cholesterol levels may impair fertility according to a recent study published in the journal JECM.
A new study has found that 69% percent of healthy American adults are infected with one or more of 109 strains of the human papillomavirus (HPV).
The 2013 Kaiser Women's Health Survey results showed how women and their health care and coverage were impacted during the Affordable Care Act (ACA) transition.
Over the past 40 years, the average age of women having first births has risen, according to a report from the National Center for Health Statistics (NCHS).
e.p.t. announced the launch of its Preconception Health Test, a new test that measures vaginal acidity and indicates the presence of infections so women can seek treatment before trying to conceive.
Compared to women with the lowest levels, women with high levels of a common liver enzyme prior to pregnancy are twice as likely to subsequently develop gestational diabetes.
The FDA has issued two proposed orders regarding surgical mesh used for transvaginal repair of pelvic organ prolapse (POP) and health risks associated with this product.
The American Heart Association has released the first scientific statement on current and recommended practices of diagnosis and management of fetal cardiac disease.
The FDA has approved Roche's cobas HPV Test, the first human papillomavirus (HPV) DNA test for women ages >25 that can be used alone to help assess the need for additional diagnostic testing for cervical cancer.
The FDA is discouraging the use of laparoscopic power morcellation for the removal of the uterus or uterine fibroids in women based on a recent analysis of currently available data.
Sentinel lymph node dissection in women with vulvar malignancies allowed gynecologic oncology surgeons to identify and remove just the sentinel nodes and follow the patients for complications and recurrence.
The variant in the gene DENND1A has been identified as a likely stimulant for the overproduction of androgen in women with polycystic ovary syndrome (PCOS).
The National Institutes of Health (NIH) reported that daily low dose aspirin therapy did not improve birth rates in most women with prior history of one or more pregnancy losses.
Non-Ob-Gyn providers delivered one out of every seven routine prenatal care visits in the United States in 2009-2010.
Ferring Pharmaceuticals announced that the FDA has approved a new labeling for Menopur (menotropins for injection) and Bravelle (urofollitropin for injection) stating that both products can be safely mixed and administered in a single injection.
For young women attending sexual health services in England, HPV vaccination uptake and completion rates are lower than national data.
The incidence of Haemophilus influenzae infection is increased during pregnancy, and infection correlates with poor pregnancy outcomes.
TherapeuticsMD, Inc. (parent company of vitaMedMD, LLC) announced the launch of vitaPearl, the latest addition to the vitaMedMD prenatal multivitamin line.
Use of nicotine patches, compared with placebo patches, does not increase the smoking cessation rate among pregnant women.
Among women who have not developed diabetes or metabolic syndrome, a history of gestational diabetes mellitus (GDM) may be a marker for early atherosclerosis.
A U.S. FDA advisory panel voted unanimously on Wednesday that a new HPV test could be used before or instead of the Pap smear as a first step in cervical cancer screening
Women who consume alcohol before pregnancy and during the first two trimesters are at increased risk for adverse pregnancy outcomes.
A U.S. Food and Drug Administration advisory panel is considering whether to delay the Pap test and use an human papillomavirus (HPV) test as a first step in cervical cancer screening.
For women born with low birth weight or small for gestational age, the odds of female-related infertility are increased.
For women with vaginal prolapse after hysterectomy and levator ani avulsion, Prolift Total is associated with a lower anatomical failure rate than unilateral vaginal sacrospinous colpopexy with native tissue vaginal repair (sacrospinous fixation).
For women undergoing surgery for vaginal prolapse and stress urinary incontinence, outcomes for two common transvaginal approaches are comparable, and perioperative behavioral therapy with pelvic floor muscle training does not improve surgical outcomes
Following a "prudent" or "traditional" diet is associated with a reduced risk of preterm delivery.
Yoga may improve menopause-related quality of life (QOL) in women with vasomotor symptoms.
A frameshift mutation in a gene encoding a cohesin subunit has been identified in a large consanguineous family with premature ovarian failure.
The human papillomavirus (HPV) vaccine is effective at protecting against cervical abnormalities in young women.
High concentrations of three common forms of phthalates in men have been shown to impact fertility in couples trying to conceive.
Low prepregnancy sex hormone-binding globulin (SHBG) concentrations correlate with increased risk of gestational diabetes mellitus.
The percentage of out-of-hospital births is continuing to increase, and in 2012 these births had a lower risk profile than hospital births.
Changing in-hospital ordering procedures increases the postpartum pertussis vaccination rate to 69%.
Women who were ever smokers during their reproductive years and those never-smoking women with the highest levels of secondhand smoke exposure have significantly increased odds for spontaneous abortion, stillbirth, and tubal ectopic pregnancy.
Use of hormonal contraceptives may be contributing to the increasing incidence of MS in women.
Fertility concerns are common among young women with newly diagnosed breast cancer, although only a minority pursue fertility preservation strategies.
Maternal plasma cell-free DNA (cfDNA) sequencing for trisomies 18 and 21 gives 5-10 fold higher positive predictive values than standard aneuploidy screening.
Use of supplementation with in-hospital formula shortens the duration of breastfeeding among first-time mothers who intend to breastfeed exclusively
Postmenopausal women are at higher risk of developing diabetes if they have both a hysterectomy and bilateral oophorectomy.
Children whose mothers took acetaminophen during pregnancy are at a higher risk for developing hyperkinetic disorders (HKDs) and attention-deficit/hyperactivity disorder (ADHD)-like behavioral problems.
Vaccination with the quadrivalent HPV vaccine is associated with reduced risk of atypia or worse (atypia+) or cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3).
Fever during pregnancy is associated with adverse health outcomes for the offspring.
An FDA panel will review information on mitochondrial manipulation to prevent mitochondrial diseases and to treat infertility.
Recommendations for preventive pediatric health care have been updated, according to an American Association of Pediatrics (AAP) policy statement.
Primary cesarean delivery rates can be safely reduced by implementing various interventions, according to an ACOG consensus statement.
For women with end-stage renal disease (ESRD), intensive hemodialysis is associated with improved pregnancy outcomes.
Compared with total vaginal hysterectomy (TVH), hospital costs are greater with laparoscopic assisted vaginal hysterectomy (LAVH), total laparoscopic hysterectomy (TLH), and robotic hysterectomy (RH).
Early fetal retinoic acid (RA) deficiency is associated with altered airway smooth muscle phenotype, with RA restricting airway smooth muscle differentiation.
Opioids are fairly commonly dispensed during pregnancy, with 14.4% of women dispensed an opioid at some point during pregnancy.
Drinking moderate to large amounts of alcohol early in pregnancy may damage the placenta and reduce the amount of taurine delivered to the fetus from the mother.
Paper wheels are inaccurate for estimating date of confinement, according to a recent study.
Women of European descent are at greater risk of entering menopause early if they smoke and carry particular gene variants.
For women, moderate to strenuous physical activity is associated with a decreased risk of stroke, even among those using postmenopausal hormone therapy.
For postmenopausal women, stellate ganglion blockade (SGB) significantly reduces objective measures of vasomotor symptoms (VMS).
Many women do not attend recommended follow-up primary care visits after delivering a child.
For postpartum women, the risk of thrombosis is elevated for at least 12 weeks after delivery.
Gestational age is inversely associated with insulin levels at birth, according to a study recently published.
Adolescent girls with major mental illness have nearly three-fold increased age-specific fertility rates, compared with unaffected girls.
For preterm infants, adult word count in the neonatal intensive care unit (NICU) correlates positively with cognitive and language development.
Young women do not engage in riskier sexual behaviors following human papillomavirus (HPV) vaccination regardless of their risk perceptions.
The second stage of labor is significantly longer for both nulliparous and multiparous women receiving an epidural.
Fetal nonsteroidal anti-inflammatory drug (NSAID) exposure is not an independent risk factor for spontaneous abortion.
In vitro fertilization (IVF) and genetic testing have been used to allow a woman with a family history of a prion disease to have healthy twins lacking the mutation.
Despite a higher neonatal mortality rate, home births have increased over the past decade, and the increased risk is associated with the location of a planned birth, rather than the credentials of the person delivering the baby.
Advanced maternal age is associated with decreased risk for major fetal congenital anomalies.
Use of estrogen-only postmenopausal hormone (PMH) treatment may help reduce the risk for primary open-angle glaucoma (POAG).